PhaseOne Australia — Full Vendor Review (2026)
- Completed Peptide Hub independent retail-sample test, with Peptester reporting 99.80% purity and 11.53mg net peptide quantity for the submitted Retatrutide 10mg sample
- Substantial public Janoshik COA library, supported by additional evidence provided to Peptide Hub regarding PhaseOne’s supplier relationship
- Completed first-hand package audit, with Sydney dispatch observed and products securely presented in good-quality packaging
- Competitive pricing across much of the catalogue, with more than 20 research products and multiple vial strengths available
- Professional, easy-to-navigate website with a dedicated laboratory section and convenient card, Apple Pay and Google Pay checkout
- Very responsive customer support, active Telegram communication and generally positive early independent customer feedback
- Most published Janoshik reports remain supplier provided rather than independently commissioned by PhaseOne from its own Australian inventory
- Batch-to-vial traceability remains limited
- Some broad website testing and purity claims could more clearly distinguish manufacturer testing, vendor-commissioned testing and independent retail-sample analysis
- PhaseOne is a relatively new vendor with a limited long-term trading history and independent community reputation
- A detailed About Us page explaining the business background, sourcing process and Australian operation would improve transparency
PhaseOne AUS Review Australia
PhaseOne AUS is an Australian research supplier with competitive comparison pricing, responsive support and a professional website. A completed package audit and a Peptide Hub independent retail-sample test add first-hand evidence to its manufacturer-supplied laboratory archive. Its longer-term public track record is still developing.
PhaseOne receives full marks for Customer Experience and Stock Consistency. More independent testing, qualifying Batch Testing links and a longer public history would strengthen its position.
Customer Experience 15/15 Independent retail test Package audit completed Developing public historyPhaseOne AUS at a Glance
PhaseOne operates through phaseoneaus.com and supplies research compounds within Australia. The supplied review records a relatively new business under the PhaseOne name. The team has described previous experience in the broader research compound market; that account is distinct from the brand’s own trading history.
PhaseOne AUS Score Breakdown
PhaseOne scores 72.7/100 on the core framework and receives 0/10 in additional Batch Testing points. It currently ranks ninth in our Australian Top 10.
| Scoring Category | Score | Recorded Evidence and Assessment |
|---|---|---|
| Independent Testing | 4 / 20 | One independent retail-sample result recorded. Wider independent coverage remains an opportunity. |
| Supplier COAs & Transparency | 4 / 5 | 21 supplier reports recorded, with manufacturer documentation assessed separately from independent testing. |
| Stock Consistency | 5 / 5 | Full marks in the final stock assessment. |
| Community Reputation | 12 / 15 | Positive recorded feedback, with a shorter public history than some established vendors. |
| Customer Experience | 15 / 15 | Responsive communication, a professional website, convenient checkout and a completed package audit. |
| Price & Value | 16.7 / 20 | Recorded pricing is 6.6% below the comparison average on assessed products. |
| Product Range | 8.7 / 10 | 31 recorded catalogue entries; strengths and formats may count separately. |
| Core Score | 72.7 / 100 | 65.4 points out of 90, rescaled to 100. |
| Batch Testing Bonus | 0 / 10 | No qualifying links between reports, current batches and supplied vials recorded in the final inputs. |
| Ranking Total | 72.7 points | Core score plus Batch Testing bonus. Current position: #9. |
Scores are reviewed monthly, or earlier when vendors submit new evidence. Scores, positions and the framework may change following review. Affiliate commission is not scored and vendors cannot pay for a higher position.
Strengths and Areas to Improve
Where PhaseOne Performs Well
- Full marks for Customer Experience and Stock Consistency.
- Competitive comparison pricing.
- A positive independent retail-sample analytical result.
- A completed package audit with secure packaging.
- 21 recorded supplier reports.
- Responsive support and professional website presentation.
What Could Lift Its Score
- More independently selected retail samples tested.
- Testing reports linked to current batches and supplied vials.
- A longer independently documented customer history.
- Clearer business background and sourcing information.
- Precise distinctions between supplier and independently commissioned reports.
PhaseOne Testing and COA Transparency
PhaseOne publishes a substantial archive of Janoshik reports supplied through its manufacturer. The archive covers many products in its catalogue and provides useful analytical information, but manufacturer-selected samples are not the same as independently purchasing and testing retail stock.
PhaseOne provided Peptide Hub with private correspondence supporting its relationship with the supplier associated with the published reports. This adds context to the sourcing relationship, although it does not independently connect every retail vial to a particular laboratory report.
Peptide Hub selected a PhaseOne AUS retail sample and submitted it to Peptester for independent laboratory analysis. This was a Peptide Hub-selected test, not a community-voted test.
The report identifies Retatrutide by MS and records chromatographic purity by RP-HPLC-UV. The declared quantity was 10mg and the reported net peptide quantity was 11.53mg/vial. These figures apply to the submitted sample only.
Verify on Peptester Website
Certificate: PT-2026-0109
Sample ID: PTA-0152
Access Key: 6PBL8AUJ
Enter the certificate number and access key on Peptester’s official verification page to unlock the live certificate.
Open Peptester Verification →Source attribution: The certificate identifies the submitted sample but does not name PhaseOne AUS as the retail source or Peptide Hub as purchaser. Peptide Hub’s purchase and submission records provide the separate provenance evidence. Those records should be published in redacted form where available. The laboratory has not independently certified the retail origin.
What the new result changes
The Peptester analysis provides a separate evidence stream from the manufacturer’s Janoshik archive. It is a positive result for the individual sample selected by Peptide Hub. It does not demonstrate that every PhaseOne product or batch meets the same specification, nor does it replace a sustained vendor-commissioned testing program.
How Should PhaseOne Describe Its Testing?
PhaseOne’s published laboratory archive is primarily manufacturer supplied. That is distinct from testing commissioned by PhaseOne itself or from Peptide Hub’s independently selected retail sample.
The new Peptester result should be described as a Peptide Hub independent retail-sample test, not as a PhaseOne-commissioned certificate. The certificate does not identify the retail source; purchase and submission records provide that separate connection.
What About the 99% Purity Claims?
Many of the manufacturer-supplied Janoshik reports reviewed by Peptide Hub show high reported purity. For example, one BPC-157 report showed approximately 10.93mg with reported purity of 99.635%. Some blend reports quantify individual ingredients but expressly state that peptide purity was not included.
The new Peptester report records 99.80% chromatographic purity for the submitted Retatrutide sample, with 11.53mg net peptide quantity against a declared 10mg. This is a positive individual-sample result, not evidence that every product meets a blanket 99% claim.
Batch Testing
Batch Testing bonus: 0/10. This bonus recognises testing reports linked to current product batches and the vials supplied.
No qualifying batch links are recorded in the final inputs. The independent test of one retail sample and the supplier archive provide useful evidence, but do not establish a complete link between reports and all current stock.
A zero bonus reflects the evidence available for those links. It does not establish that no batch testing takes place.
Pricing and Value
PhaseOne earns 16.7/20 for Price & Value. The final comparison inputs place its prices 6.6% below the comparison average on the products assessed.
This is a comparison of assessed products, not every catalogue item or a total-basket quote. Current prices, shipping fees and promotional conditions may change.
The supplied review recorded a historical storewide sale. Temporary promotions are distinct from the normal retail pricing used for ranking wherever possible.
Stock Consistency and Product Range
PhaseOne receives 5/5 for Stock Consistency and 8.7/10 for Product Range. The final inputs record 31 catalogue entries. Different vial strengths or formats may count separately; this is not a count of 31 distinct compounds.
The reviewed catalogue includes compounds such as BPC-157, TB-500, Retatrutide, GHK-Cu, Tesamorelin, Ipamorelin, Semax and Selank, plus blends and supporting laboratory items. Confirm current stock directly.
Full marks reflect the recorded stock assessment rather than a guarantee that every item will always be available.
Customer Experience, Shipping and Payment
PhaseOne receives 15/15 for Customer Experience. The supplied review records responsive support, straightforward checkout, a professional website and an active Telegram presence.
Questions during the review process were regularly answered within minutes. The package audit adds first-hand fulfilment evidence to those communication observations.
Recorded Shipping Terms
- Australian domestic fulfilment.
- Sydney dispatch observed in the audit.
- Free express shipping over $100 advertised in the supplied review.
- Next-day dispatch advertised, with same-day dispatch where possible.
Recorded Payment Options
- Visa and Mastercard.
- American Express.
- Apple Pay and Google Pay.
- Standard online checkout.
Service terms and payment methods are retained from the supplied review rather than newly verified current promises. Confirm current conditions directly.
PhaseOne AUS Package Audit
Peptide Hub has completed an independent packaging audit of a PhaseOne AUS retail order. Sydney dispatch was observed, and the products arrived in basic but good-quality packaging, securely presented for domestic delivery.
What we observed
Dispatch: Sydney dispatch observed.
Packaging: Basic but good quality, with products securely presented for domestic delivery.
Status: Completed first-hand audit.
View Package Photos →The audit records the presentation and fulfilment of one order. It does not establish consistent delivery performance, product identity, purity, sterility or suitability for human use.
Community Reputation
PhaseOne receives 12/15 for Community Reputation under the final assessment. Recorded independent purchaser feedback is encouraging, including comments about delivery and repeat orders.
The public history remains shorter than that of some established vendors. Anonymous forum comments and reviews hosted by the vendor are considered with their source and limitations in mind.
The final score replaces the older reputation score in the supplied review. Continued feedback over time will help establish whether the early pattern is sustained.
Website and Business Transparency
The supplied review describes a clean, modern website with individual product pages, public laboratory information, shipping details and accessible customer support. Website usability contributes to Customer Experience under the current framework rather than a separate ten-point category.
The review identifies limited business background as an opportunity to improve. A dedicated About Us page could explain the company’s history, fulfilment, sourcing and testing process without disclosing sensitive personal information.
Testing claims should distinguish manufacturer-supplied reports, vendor-commissioned tests and independent retail-sample analysis.
Final Verdict
PhaseOne AUS scores 72.7/100 and ranks ninth in our current Australian Top 10. Customer experience, stock consistency, competitive pricing and useful supplier documentation support its position.
The independently selected Retatrutide sample adds a separate analytical evidence stream. Wider independent testing, clear links between reports and supplied batches, and a longer public history are the clearest ways to strengthen the assessment.
PhaseOne AUS FAQs
What is PhaseOne’s current Peptide Hub score?
PhaseOne scores 72.7/100 on the core framework, receives 0/10 in Batch Testing bonus points and ranks ninth in our current Australian Top 10.
How many testing reports are recorded?
The final inputs record one independent result and 21 supplier reports. These are assessed separately.
Has Peptide Hub independently tested PhaseOne?
Yes. Peptide Hub selected a retail sample described as PhaseOne AUS Retatrutide 10mg and submitted it to Peptester. The report dated 8 September 2026 records 99.80% purity and 11.53mg net peptide quantity. The certificate does not itself identify the retail source.
How can I verify the Peptester result?
Use the report link above or the official Peptester verification page with certificate PT-2026-0109 and access key 6PBL8AUJ. The sample ID is PTA-0152.
Has a package audit been completed?
Yes. Sydney dispatch and basic but good-quality packaging were observed, with the products securely presented for domestic delivery.
Why is the Batch Testing bonus zero?
No qualifying links between reports, current batches and supplied vials are recorded in the final inputs. This does not establish that no batch testing takes place.
How does PhaseOne compare on price?
The final inputs place PhaseOne 6.6% below the comparison average on the products assessed, earning 16.7/20 for Price & Value.
Does the laboratory result establish safety?
No. The findings concern one submitted sample and do not establish sterility, endotoxin status, regulatory approval, suitability for human use or the composition of other vials.
Can its score change?
Yes. Scores are reviewed monthly, or earlier when new evidence is submitted. Scores and positions can rise, fall or remain unchanged.
View PhaseOne AUS
Check current stock, pricing, shipping terms and laboratory documentation.
Visit PhaseOne AUS